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Summary.-MSC-10 tumour cells (derived from a chemically induced pulmonary
squamous-cell carcinoma in DBA/2 mice) were inoculated intramuscularly into
thymectomized, X-irradiated isogeneic mice, either48 h or6 weeks afterthymectomy
and X-irradiation. Normal mice and immunologically reconstituted mice served as
controls. A marked enhancement in frequency of tumour takes was observed in all
groups of animals inoculated with tumour cells 48 h after whole-bodyX-irradiation,
whether thymectomized, immunologically reconstituted or not. The TD50 decreased
to less than 1/10 ofthat observed in unirradiated controls. When mice were inoculated
with tumour cells 6 weeks after X-irradiation, the incidence of tumour takes was
similar to that of unirradiated controls, including the thymectomized-irradiated
group, which was still severely immunodeficient as measured by antibody formation
and skin graft rejection. The experiments indicate that whole-body X-irradiation
creates a condition that favours tumour cell survival or growth. This "permissive
state" exists only shortly after X-irradiation and is not correlated with the host's
level of immunocompetence.
IN RECENT work (Jamasbi and
Nettesheim, 1977) we describe the
immunological characteristics of a trans-
plantable pulmonary squamous-cell car-
cinoma (MSC-10) originally induced in a
DBA/2 mouse with 3-methylcholanthrene.
We found it impossible to induce any
detectable degree of transplantation im-
munity with a variety of immunization
procedures (e.g., repeated immunization
with X-irradiated tumour cells and/or by
transplanitation-excision method) and con-
cluded that this tumour was non-immuno-
genic (which is not to say that the tumour
could not have antigens associated with
it).
The original purpose of the studies
presented here was to determine whether
it was possible to detect any subtle
immune reactivity against the tumour by
comparing the frequency of tumour takes
and growth rates in normal and thy-
mectomized, X-irradiated, immunologi-
cally suppressed mice. Our studies yielded
no indication of an immunological host
anti-tumour response. Instead they pro-
duced strong evidence that frequency of
tumour take (probably due to increased
survival of tumour cells) is markedly
enhanced in whole-body X-irradiated
recipients, and that this enhancement is
not mediated by an immunological mech-
anism. Similar findings and conclusions
were recently reported by Peters (1975)
with a spontaneous adenocarcinoma
derived from a CBA mouse. We feel that
this enhancing effect of X-irradiation
on survival of tumour cells, if it also
occurs in humans, might have to be
considered when weighing the relative
risks and benefits of X-irradiation in
cancer therapy.
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MATERIALS AND METHODS
Mice.-We used inbred male DBA/2
(H-2d) mice 8-10 weeks old at the start ofthe
experiment. The animals were maintained in
filter-top cages with free access to food and
water.
Tumour.-The mouse squamous-cell car-
cinoma (MSC-10) used was originally induced
in a male DBA/2 mouse by intra-tracheal
injection of 3-methylcholanthrene (Nettes-
heim and Hammons, 1971). The tumour line
has been maintained by serial passages in the
strain of origin. Some of the in vivo charac-
teristics of this tumour line were reported
recently (Williams and Nettesheim, 1973).
Frozen pools of tumour-cell suspensions from
the 10th in vivo passage were used throughout
our studies.
Tumour-cell inoculation.-After thawing,
the tumour cells were spun down and resus-
pended in Hanks' solution containing 5%
foetal calf serum (FCS). Viability was
determined by trypan-blue exclusion. Cell
counts were made with a haemacytometer,
and the cell suspensions were adjusted to the
desired concentrations.
After inoculation of 104 or 103 tumour cells
into the thigh muscle, mice were inspected
for tumour development every other day
from Day 10 on. Incidence of tumour take,
tumour growth rate and mortality were
recorded for a 70- to 100-day period.
Thymectomy.-Adult thymectomy wasdone
on 8- to 10-week-old mice according to the
technique described by Gross (1959). At the
end of the experiments the mice were autop-
sied, and the absence of thymic tissue was
ascertained by gross and microscopic inspec-
tion. Controls were sham-thymectomized.
Immunological reconstitution.- Whole
thymuses from 3-week-old syngeneic donors
were implanted i.p. within 24 h after whole-
bodyX-irradiation (onethymus perrecipient).
For preparation of spleen-cell suspensions,
spleens from syngeneic donors were aseptic-
ally removed. The spleen-cell donors were
8-10 weeks old. Single-cell suspensions were
prepared and were passed through sterile
200-mesh stainless steel sieves. The cells were
washed in Hanks' balanced salt solution with
10% FCS added. Each mouse received 2 x 108
viable spleen cells i.p. within 24 h after
irradiation.
X-irradiation.-Normal or thymectomized
mice (2 weeks after removal of thymus)
were exposed to 600 rad whole-body X-
irradiation. Exposures were administered
with a 300kVp X-ray unit (GE Maxitron 300)
operated at 20 mA, with an added filtration
of 3 mm Al and a target-to-object distance
of 60 cm. The exposure rate averaged
180 rad/min. The animals were irradiated in
a perforated Lucite container attached to a
revolving turntable.
Measurement of humoral and cellular im-
munity.-Mice were injected i.p. with 108
sheep red blood cells (SRBC) to induce
antibody production. Animals were bled via
the tail vein at 4 and 10 days after SRBC
injection, and haemagglutinin titres were
determined for each animal by standard tube
haemagglutinin tests. To test cellular im-
munity, DBA/2 mice (H-2d) were grafted
with C3H (H-2k) mouse skin according to the
method of Billingham and Medawar (1951).
Skin from isogeneic donors was used for
control grafts.
The animals were inspected daily from
Day 8 on, and the condition ofthe grafts was
recorded. The day of complete destruction of
the grafts was taken as the time of graft
rejection.
RESULTS
Effect of thymectomy and X-irradiation on
host resistance to tumour transplantation
Eight- to 10-week-old mice were thy-
mectomized and given a single dose of
600 rad whole-body X-irradiation 2 weeks
later. Sham-thymectomized, unirradiated
mice served as controls. Forty-eight hours
after X-irradiation, the experimental and
control animals were inoculated i.m. with
either 103 or 104 live MSC-10 tumour
cells.
Results of this experiment are summa-
rized in Fig. 1. In the sham-operated, un-
irradiated animals, a tumour-cell inoculum
of 104 live MSC-10 cells (injected i.m.)
produced tumours in only 50% of the
animals (TD5o) whereas the same tumour-
cell dose produced 100% tumours in
thymectomized, X-irradiated mice. Inci-
dence of mortality followed similar trends
(data not shown). The dose of 103 MSC-10
tumour cells (one tenth the TD5o) failed
to produce tumours in any of the sham-
treated control animals, but produced
724X-RAY ENHANCEMENT TUMOUR TRANSPLANTABILITY
iuu -
80-
c 60-
0
- 40-
o--
20-
0
0/
/ /.-t_.-^ A
0-0 a /
0 A A !
o A ........ , .... , .. .. . ._
O 10 20 30 40 50 60 70
TIME AFTER TUMOUR CELL INOCULATION (days),
FIG. 1.-Effect of thymectomy and X-irradia-
tion on the frequency of tumour take.
Animals were exposed to 600 rad of
whole-body X-irradiation 2 weeks after
removal of thymus glands. Treated and
sham-operated mice were challenged i.m.
with either 104 or 103 live MSC-10 tumour
cells 48 h after X-irradiation. Thymecto-
mized, X-irradiated group (0), and in the
sham-thymectomized, unirradiated group
(A) receiving 104 MSC-10 cells. Thymecto-
mized, X-irradiated groups (A), and in the
sham-thymectomized, unirradiated group
(A) receiving 103 MSC-10 cells. (20 mice per
group.)
tumours in 70% of the thymectomized,
X-irradiated mice.
Effect of immunological reconstitution on
host resistance to tumour transplantation.
Thymectomized, irradiated recipients
received 2 x 108 syngeneic spleen cells
and thymic implants i.p. within 24 h
after X-irradiation. Some ofthe mice were
tested for immunocompetence and others
were inoculated with live MSC-10 tumour
cells at 48 h after whole-body X-irradia-
tion. The various types of control groups
were tested simultaneously.
The results of the tests for immuno-
competence are summarized in the upper
halves ofTables I and II. Thymectomized,
aswell assham-thymectomized, X-irradia-
ted mice showed severe impairment of
humoral immune response as measured
by the haemagglutinin assay. The skin
allograft response was severely suppressed
in thymectomized, X-irradiated animals
and only slightly suppressed in sham-
thymectomized, X-irradiated mice. After
reconstitution with spleen cells and
thymus, the humoral immune response
still appeared to be markedly impaired,
whilst the skin allograft survival time was
only slightly different from that of normal
control animals.
The results of the tumour transplanta-
tion studies are summarized in Fig. 2.
All three X-irradiated groups showed a
marked increase in the incidence of
tumour take and mortality, even when
the animals were reconstituted withspleen
cells and had received thymus grafts.
Tumour growth rates (not shown) showed
no consistent differences between groups.
TABLE I.-Effect of Immunological Reconstitution on the Haemagglutinin Response of
Thymectomized Mice Receiving 600 rad of Whole-body X-irradiation 48 h or 6 Weeks
before SRBC Injections*
Treatment t
Thymectomy, 600 rad
Sham thymectomy, 600 rad
Thymectomy, 600 rad, reconstituted I Sham thymectomy, 0 rad
Thymectomy, 600 rad
Sham thymectomy, 600 rad
Thymectomy, 600 rad, reconstituted t
Sham thymectomy, 0 rad
Mean log2 haemagglutinin titre
(I s.e.)
Day 4 Day 10
(48 h after irradiation)
Undetectable TJndetectable
Undetectable Undetectable
2-2 i03 3-1±07
6-8 ± 0 4 8-6 ± 0-3
(6 weeks after irradiation)
Undetectable Undetectable
6-4 i 03 7-6 ± 0-3
5-0 ± 04 6-0 ± 0-6
8-4 0-3 9-8 0-1
* 108 SRBC injected i.p. either 48 h or 6 weeks after exposure to whole-body X-irradiation.
t 10 mice per treatment group.
t 2 X 108 syngeneic spleen cells and a whole thymic graft within 24 h after X-irradiation.
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TABLE II.-Effect of Imrmunological Reconstitution on the Skin Allograft (Donor C3H)
Response ofThymectomized Mice Receiving 600 rad of Whole-body X-irradiation 48 h
or 6 Weeks before Skin Grafting*
Treatment t
Thymectomy, 600 rad
Sham thymectomy, 600 rad
Thymectomy, 600 rad, reconstituted t
Sham thymectomy, 0 rad
Thymectomy, 600 rad
Sham thymectomy, 600 rad
Thymectomy, 600 rad, reconstituted I
Sham thymectomy, 0 rad
Mean skin-graft
survival
(days + s.e.)
(48 h after irradiation)
> 60
16-1 ± 05
14-5 + 0 9
12-3 ± 0-6
(6 weeks after irradiation)
> 60
11-2 ± 0-6
12-4 ± 0-6
11-2 ± 0-6
* Grafts performed either 48 h or 6 weeks after exposure to whole-body X-irradiation.
t 10 mice per group.
1 2 x 108 syngeneic spleen cells and a whole thymic graft within 24 h after X-irradiation.
In a subsequent study, similarly treated
groups of mice were tested for immuno-
competence and resistance to tumour
transplantation 6 weeks after whole-body
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FIG. 2. Effect of immunological reconstitu-
tion on tumour transplantability in thy-
mectomized mice receiving whole-body X-
irradiation 48 h before tumour-cell inocula-
tion. Animals were exposed to 600 rad of
whole body X-irradiation 2 weeks after
removal of thymus glands. Each mouse in
the reconstituted group received 2 x 108
syngeneic spleen cells and one thymic graft
within 24 h after X-irradiation. Treated
and sham-operated controls were chal-
lenged i.m. with 104 live MSC-10 tumour
cells 48 h after X-irradiation. Thymecto-
mized, X-irradiated group (0); thymecto-
mized, X-irradiated reconstituted group
(LO); sham-thymectomized, X-irradiated
group (Q); sham-thymectomized, unirra-
diated group (A). (20 mice per group.)
0
0 20 40 60 80 100
TIME AFTER TUMOUR CELL INOCULATION (days)
FIG. 3.-Effect of immunological reconstitu-
tion on tumour transplantability of thy-
mectomized mice receiving whole-body
X-irradiation 6 weeks before tumour-cell
inoculation. Animals were exposed to 600
rad of whole-body X-irradiation 2 weeks
after removal of thymus glands. Each
mouse in the reconstituted group received
2 x 108 syngeneic spleen cells and one
thymic graftwithin24hafterX-irradiation.
Treated and sham-operated controls were
challenged i.m. with 104 live MSC-10
tumour cells 6 weeks after X-irradiation.
Thymectomized, X-irradiated group (0);
thymectomized, X-irradiated, reconstitu-
ted group (LO); sham-thymectomized,
irradiated group (Q); sham-thymecto-
mized, unirradiated group (A). (20 mice
per group.)
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TABLE III.-Influence of Host Immunological Competence on the Development
of Distant Metastases*
Treatment t
Thymectomy, 600 rad
Sham thymectomy, 0 rad
No. of mice
with lung
metastases
10
12
Mean no. of
lung tumours/
mouse
(± s.e.)
7-1 ± 3-9
7-3 ± 6-4
Mean size of
nodules
(mm3 ± s.e.)
35 ± 11-0
30 ± 8 - 7
* Thymectomized, X-irradiated mice and sham-operated controls were inoculated i.m. with 2 x 104 live
MSC-10 tumour cells 6 weeks after exposure to 600 rad whole-body X-irradiation. Tumour-bearing legs
were removed 4 weeks after inoculations. These mice were killed 4 weeks after surgery and the number and
size of lung metastases were determined.
t 20 mice per group.
X-irradiation and inoculation of immuno-
competent cells. We chose a 6-week
period between X-irradiation-reconstitu-
tion and testing to allow time for recovery.
The results of this study are summarized
in the lower halves of Tables I and II and
in Fig. 3. The immunological studies
showed partial and complete recovery,
respectively, of the haemagglutinin and
the homograft-rejection response in all
but the thymectomized X-irradiated
mice. This latter group showed no signs of
immunological recovery. The tumour
transplantation studies however, show
that all groups of animals have reacquired
an almost normal degree of resistance to
tumour-cell inoculation, namely that of
unirradiated, sham-thymectomized, age-
matched controls (seeFig. 3). Only40-50/
ofthe animals developed tumours. Tumour
development was actuallyslightly retarded
in groups that had received X-irradiation
6 weeks earlier.
Incidence of tumour metastases in immuno-
suppressed mice
A total of 20 mice were thymectomized
and subsequently exposed to 600 rad of
whole-body X-irradiation. Six weeks after
X-irradiation, a time when humoral as
well as cellular immune competence is
still severely suppressed (see Tables I and
II,) the above group of animals and age-
matched, sham-operated control animals
were challenged with 2 x 104 live tumour
cells given i.m. The tumour-bearing legs
were removed 4 weeks after inoculation.
After a further 4 weeks, all animals were
killed. Their lungs were removed and
fixed, and the number of metastatic
nodules was established in cleared and
stained lungs with a dissecting microscope
(Yuhas, 1973). The results (Table III)
show that the incidence of tumour meta-
stasis is not affected by the immuno-
suppressed state (no metastases were
found in any organs other than the lungs.).
DISCUSSION
The lung squamous-cell carcinoma
(MSC-10) is a highly metastatic malignant
tumour displaying no, or very weak,
immunogenicity, since it is incapable of
producing humoral immunity (determined
by indirect immunofluorescent antibody
techniques and radioimmunoassays) or
inducing tranplantation resistance in syn-
geneic hosts (demonstrated by trans-
plantation-excision method and Winn
neutralization tests; Jamasbi and Nette-
sheim (1977). This study was concerned
with the question of whether immuno-
suppression induced by thymectomy and
whole-body X-irradiation would signifi-
cantly affect survival and growth of cells
from this tumour line in syngeneic hosts.
The key findings are as follows:
(a) Animals treated with whole-body
X-irradiation (with or without thy-
mectomy) show marked decrease
in resistance (or enhanced suscepti-
bility), by a factor of , 10, to
tumour-cell inoculation shortly after
X-irradiation.
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(b) This altered host status is not abro-
gated by infusion of immunocom-
petent cells (which partially restores
host immunological competence).
(c) Six weeks after X-irradiation (with
orwithout thymectomy) the animals
reacquired a "normal" level of host-
resistance to tumour transplanta-
tion, regardless of their immuno-
logical status (i.e., X-irradiated
thymectomized mice still have
severely depressed immune func-
tions, as measured by antibody
formation and skin-graft rejection,
yet their resistance to tumour
transplantation is the same as that
of controls or of immunologically
reconstituted mice).
(d) The incidence of spontaneous
tumour metastasis is not different
from controls in severely immuno-
suppressed mice 6 weeks after
X-irradiation and thymectomy.
The following tentative conclusions can
be drawn from these findings. Even in
severe states of humoral and cellular
immune suppression, local tumour growth,
as well as development of distant meta-
stases, may not be significantly altered
from normal ifthe tumour is not immuno-
genic or only weakly so. The "natural"
host-resistance to tumour transplantation
is impaired shortly after exposure to a
sublethal dose of X-irradiation. However,
at least in the case of poorly immuno-
genictumours, this is not a result ofX-ray-
induced immune suppression, since this
decreased resistance vanishes with time,
even when the state of immunosuppress-
ion persists, as in thymectomized, X-
irradiated mice.
Our findings confirm and extend those
reported by Peters (1975) obtained with a
late-transplant generation of tumour cells
derived from a spontaneous adenocar-
cinoma. He showed that the TD50 was
markedly reduced in whole-body, X-
irradiated mice up to at least 4 days after
X-irradiation, but was normal in mice
made immunodeficient by thymectomy
plus X-irradiation several months prior to
inoculation of tumour cells. Laparotomy
also reduced the TD50, but this effect was
less reproducible, less striking, and lasted
for only a few hours. Attempts to correlate
this enhanced transplantability of tumour
cells with increased plasma fibrinogen
levels failed. Whether the increased inci-
dence of artificial lung metastases, fol-
lowing irradiation of the lung and subse-
quent i.v. inoculation oftumour cells (e.g.,
van den Brenk et al., 1973; Withers and
Milas, 1973) is the same or a related
phenomenon is not certain. Withers and
Milas (1973) interpreted this as an X-ray
effect on the capillary bed of the lung.
It is possible that the X-ray enhance-
ment of tumour-cell survival reported
here might easily be overlooked in studies
with more immunogenic tumours, since
the immunosuppressive effect ofX-irradia-
tion would tend to overshadow the pheno-
menon. This may be the reason why this
apparent non-immunological effect of X-
irradiation has not been reported more
frequently.
Whether or not the enhanced survival
of tumour cells following X-irradiation,
and the enhancement of metastases fol-
lowing surgical trauma (for discussion
see Peters, 1975) are related phenomena is
presently unclear. However, since cancer
patients are commonly subjected to either
or both procedures, it seems that further
elucidation of the mechanisms involved is
highly desirable.
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